Apple Cider Vinegar Soaks: No Skin Barrier Boost for Eczema

observational-study PMID: 31328306

Quick Summary: A small 2019 study tested if soaking arms in diluted apple cider vinegar (ACV) could help the skin barrier in people with atopic dermatitis (eczema). It found no lasting improvements in skin moisture loss or pH balance. Instead, most participants experienced mild irritation, suggesting ACV soaks aren't a safe or effective option for eczema relief.

What The Research Found

Researchers hoped ACV soaks might strengthen the skin's protective layer, which is often weak in eczema, leading to dryness and infections. But the results showed no real benefits. Right after soaking, skin lost more moisture and became slightly more acidic, but these changes faded within an hour. Over two weeks, ACV didn't improve skin health compared to plain water soaks. Plus, over 70% of people felt stinging or burning, which stopped once they quit using it. This means ACV soaks don't fix the high water loss or high pH common in eczema skin.

Study Details

Who was studied: 22 adults—11 with mild eczema and 11 with healthy skin—to compare effects.

How long: 14 days of daily 10-minute soaks on both forearms.

What they took: One arm soaked in water mixed with 0.5% ACV (a weak dilution, like a mild vinegar rinse); the other in plain water as a control.

What This Means For You

If you have eczema and are thinking about trying apple cider vinegar soaks to soothe dry, irritated skin, this study says skip it. The irritation could make your skin feel worse, especially since eczema already weakens your skin barrier. Stick to proven treatments like moisturizers, steroid creams, or doctor-recommended baths. Always talk to a dermatologist before home remedies—ACV might help in other ways, like digestion, but not for skin barrier issues here. For eczema relief, focus on gentle, pH-balanced products to lock in moisture without the sting.

Study Limitations

This was a small pilot test, so results might not apply to everyone or larger groups. They only used one ACV brand at 0.5% strength and soaks, not creams or lower doses. It didn't check long-term effects or severe eczema cases. No blinding meant people knew what they were using, which could affect reports of irritation. More research is needed on safer ways to use ACV, like milder versions, to see if it could help skin without causing problems.

Key Findings

The 2019 observational split-arm study found that dilute apple cider vinegar (ACV) soaks (0.5% acetic acid) did not significantly improve skin barrier integrity in individuals with atopic dermatitis (AD) or healthy controls. While transient changes in skin pH and transepidermal water loss (TEWL) were observed immediately post-treatment, these effects dissipated within 60 minutes. Notably, 72.7% of participants (16/22) reported mild skin irritation from ACV, which resolved after discontinuation.

Study Design

This was a small, observational pilot study with a split-arm design, enrolling 22 participants (11 with AD and 11 healthy controls). Each subject soaked both forearms daily for 10 minutes over 14 days: one arm in 0.5% ACV solution, the other in water. Skin barrier integrity was assessed via TEWL and pH measurements pre-treatment, immediately post-soak (0 minutes), and 60 minutes post-treatment. The study aimed to evaluate ACV’s acute and short-term effects but was not randomized or blinded.

Dosage & Administration

ACV was standardized to 0.5% acetic acid concentration (diluted in water). Participants soaked each forearm separately for 10 minutes daily, with one arm receiving ACV and the other water. The protocol lasted 14 consecutive days.

Results & Efficacy

TEWL: Increased immediately post-ACV soak in both AD and healthy groups but normalized within 60 minutes (no sustained effect).
Skin pH: Decreased post-treatment but returned to baseline at 60 minutes.
Comparisons: No statistically significant differences in TEWL or pH between ACV and water arms at any time point (p-values not explicitly reported in summary).
Safety: 72.7% of subjects experienced mild irritation (e.g., burning, stinging) with ACV, though effects were reversible.

Limitations

Small sample size: Only 22 participants, limiting statistical power.
Single concentration/application method: Tested only 0.5% ACV soaks; results may not apply to lower concentrations or alternative formulations (e.g., leave-on ointments).
Short-term assessment: Measured acute effects (14 days) without long-term follow-up.
Lack of standardization: Used a single ACV brand, which may vary in composition from others.
Potential bias: Open-label design without blinding could influence subjective symptom reporting.
Mild AD cases: Clinical relevance for severe AD remains unclear.

Clinical Relevance

This study suggests that dilute ACV soaks (0.5%) are unlikely to benefit skin barrier function in AD patients or healthy individuals. The high incidence of irritation (72.7%) raises safety concerns, particularly for those with compromised skin barriers. Clinically, ACV soaks should not be recommended for AD management based on these findings. However, the results do not rule out potential benefits of other acidic formulations (e.g., pH-balanced moisturizers) or lower ACV concentrations. Larger, controlled trials are needed to explore alternative delivery methods and their efficacy in AD treatment. Users should prioritize evidence-based therapies and consult dermatologists before trying ACV for skin conditions.

Word count: 398